BAMS
HZNP

Bellevue Asset Management (Switzerland)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$5.31M Buy
245,000
+25,000
+11% +$487K 0.81% 42
2015
Q3 		$4.36M Buy
220,000
+70,000
+47% +$2.21M 0.71% 51
2015
Q2 		$5.21M Buy
+150,000
New +$4.58M 0.72% 49

Other funds holding HZNP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s HZNP Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 11% in Q4 2015, buying an estimated $487K and bringing the position to 245,000 shares worth $5.31M. The position accounts for 0.81% of the portfolio, ranked #42.

Bellevue Asset Management (Switzerland) first reported a position in HZNP in Q2 2015 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold HZNP as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 245,000 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $5.31M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) bought 25,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2015, an estimated $487K.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.81% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #42 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and has held it in 3 quarters since.
  • 202 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.